The report detailed numerous multi-million-dollar discrepancies in intercompany receivables and loans across Marex's network of over 56 entities. Examples of these discrepancies included a fabricated $17 million receivable, a subsidiary with profits inflated by 150% before liquidation, and an asset valued at $14.9 million sold weeks later for just $2.5 million with no reported loss. The report also alleged nearly $1 billion in off- balance-sheet derivatives exposure concealed through a Marex-controlled fund ...